These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1321 related items for PubMed ID: 24004438
21. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. van Lummel M, van Blitterswijk WJ, Vink SR, Veldman RJ, van der Valk MA, Schipper D, Dicheva BM, Eggermont AM, ten Hagen TL, Verheij M, Koning GA. FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209 [Abstract] [Full Text] [Related]
22. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y, Gao S. J Nanobiotechnology; 2019 Sep 03; 17(1):93. PubMed ID: 31481080 [Abstract] [Full Text] [Related]
23. Reduction Responsive Nanovesicles Derived from Novel α-Tocopheryl-Lipoic Acid Conjugates for Efficacious Drug Delivery to Sensitive and Drug Resistant Cancer Cells. Maiti B, Kumar K, Moitra P, Kondaiah P, Bhattacharya S. Bioconjug Chem; 2018 Feb 21; 29(2):255-266. PubMed ID: 29268009 [Abstract] [Full Text] [Related]
24. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery. Lu M, Zhao X, Xing H, Liu H, Lang L, Yang T, Xun Z, Wang D, Ding P. Acta Biomater; 2019 Sep 15; 96():517-536. PubMed ID: 31284098 [Abstract] [Full Text] [Related]
25. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics. Zhang P, Chen H, Liu J, Liu G. Methods Mol Biol; 2019 Sep 15; 2054():283-294. PubMed ID: 31482462 [Abstract] [Full Text] [Related]
26. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo. Li M, Wang J, Guo P, Jin L, Tan X, Zhang Z, Zhanghuang C, Mi T, Liu J, Wang Z, Wu X, Wei G, He D. Biomater Adv; 2022 Nov 15; 142():213161. PubMed ID: 36308859 [Abstract] [Full Text] [Related]
31. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy. Di Francesco M, Celia C, Primavera R, D'Avanzo N, Locatelli M, Fresta M, Cilurzo F, Ventura CA, Paolino D, Di Marzio L. Int J Pharm; 2017 Aug 07; 528(1-2):18-32. PubMed ID: 28559215 [Abstract] [Full Text] [Related]
38. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L. J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599 [Abstract] [Full Text] [Related]
39. Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Chen T, Xu S, Zhao T, Zhu L, Wei D, Li Y, Zhang H, Zhao C. ACS Appl Mater Interfaces; 2012 Nov 01; 4(11):5766-74. PubMed ID: 23043448 [Abstract] [Full Text] [Related]